Shares of Matthews International Corporation find themselves at a crossroads, caught between bullish long-term analyst projections and more immediate, mixed quarterly results. The investment community is closely watching as the company balances recent earnings disappointments against significant upward revisions for its future profitability.
Institutional Positioning and Market Activity
Recent regulatory filings reveal notable repositioning by major institutional investors, signaling continued professional interest in Matthews. Nuveen LLC established a substantial new position, acquiring 115,913 shares valued at approximately $2.58 million. Other significant institutional movements included:
- Squarepoint Ops LLC increased its holdings by 16,039 shares, bringing its total position to 34,813 shares
- Public Sector Pension Investment Board grew its stake by 7.4%, now holding 105,494 shares
- Tower Research Capital LLC dramatically expanded its position with a 187.1% increase during the second quarter
These strategic adjustments among sophisticated investors suggest ongoing reassessment of Matthews’ market position and future prospects.
B. Riley’s Revised Financial Projections
Investment firm B. Riley has issued substantially upgraded long-term projections for Matthews, significantly raising its 2026 earnings per share estimate from $0.35 to $1.19. This aggressive upward revision indicates growing confidence in the company’s path to sustained profitability.
However, the analyst simultaneously tempered expectations for the nearer term, reducing its 2025 full-year EPS forecast from $1.03 to $0.97. For the fourth quarter specifically, B. Riley now anticipates earnings of just $0.22 per share. Despite these mixed near-term signals, the analyst community maintains its consensus buy rating with an average price target of $40.00.
Quarterly Performance: Revenue Beat Amid Earnings Shortfall
Matthews reported its third-quarter results on August 5, presenting a complex financial picture. While the company posted adjusted earnings of $0.28 per share, this figure fell $0.05 short of market expectations. Conversely, revenue performance proved stronger than anticipated, with $349.40 million in sales exceeding projections.
Should investors sell immediately? Or is it worth buying Matthews?
The company’s GAAP earnings showed dramatic improvement, jumping to $0.49 per share compared to $0.06 during the same period last year. This substantial increase was primarily driven by the strategic divestiture of the SGK business segment. Both remaining divisions—Memorialization and Industrial Technologies—recorded higher adjusted EBITDA figures.
Key financial developments included:
* Reduction of outstanding debt by $120 million
* Declaration of a quarterly dividend of $0.25 per share, representing a 4.1% yield
* Reaffirmation of the full-year 2025 adjusted EBITDA guidance of at least $190 million
Current Financial Metrics and Trading Patterns
Matthews currently maintains a market capitalization of $759.74 million. The company’s negative P/E ratio of -11.64 reflects its current lack of positive earnings. With a beta coefficient of 1.27, the stock demonstrates above-average volatility compared to the broader market.
Additional financial ratios include:
* Current Ratio: 1.66
* Quick Ratio: 0.98
* Debt-to-Equity Ratio: 1.35
Over the past twelve months, Matthews shares have traded between $18.50 and $32.24, closing most recently at $24.89.
Ad
Matthews Stock: Buy or Sell?! New Matthews Analysis from February 7 delivers the answer:
The latest Matthews figures speak for themselves: Urgent action needed for Matthews investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Matthews: Buy or sell? Read more here...
